Acide Ascorbique Renaudin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acide Ascorbique Renaudin

Property Description
Active ingredient Acide Ascorbique (Vitamine C)
Specific Composition Sodium Ascorbate (Buffered salt form)
Form Solution injectable (Injectable solution)
Pharmacological class Vitamine hydrosoluble (Water-soluble vitamin)
Origin Synthétique (Synthetic)

Acide Ascorbique Renaudin: Identity and Pharmacological Class

Acide Ascorbique Renaudin is classified as a médicament (drug) whose core active substance is Acide Ascorbique (L-Ascorbic Acid), commonly known as Vitamine C. The medicine is a produit simple (single-ingredient product) belonging to the high-level pharmacological class of Vitamines, specifically designated as a Vitamine hydrosoluble (water-soluble vitamin). Its high-level purpose is to provide the body with this essential nutrient, which is clinically recognized for its necessity in various metabolic pathways. As a water-soluble compound, it requires frequent replenishment; thus, the medicine is typically used in scenarios of confirmed deficiency or where the oral route is compromised.

Composition and Dosage Form: The Parenteral Buffered Salt

This formulation, presented by the manufacturer Renaudin, is a sterile solution injectable (injectable solution) intended for administration via the voie parentérale (parenteral route). This presentation focuses on ensuring rapid systemic delivery. The specific active component used is Sodium Ascorbate (Ascorbate de Sodium), which is a sel minéral (mineral salt) of the acid. This composition is a key differentiating feature, as the Sodium Ascorbate creates a forme tamponnée (buffered form) that is nearly pH-neutral. This neutral composition is pharmacologically essential for maintaining the stability and physiological compatibility of the solution during administration, unlike the more acidic pure Acide L-Ascorbique.

General Purpose and Essential Role of Vitamine C

The general purpose of Acide Ascorbique Renaudin is to prevent or rapidly correct severe carence en Vitamine C (Vitamin C deficiency). The essential role of the vitamin derives from its powerful antioxydant (antioxidant) function, which contributes to the protection of cells from stress oxydatif (oxidative stress). This function is integral to sustaining tissue health, assisting in the proper formation of collagène (collagen), and supporting general metabolic activities.

What side effects are possible with Acide Ascorbique Renaudin?

Possible Side Effects and Safety Information

The safety profile for Acide Ascorbique (Vitamin C, as Sodium Ascorbate injectable solution) is officially documented by regulatory agencies and is structured around risks tied to the compound's metabolism and the route of administration.


Systemic and Organ-Specific Safety Concerns

Adverse reactions are classified by the physiological system affected. Common, non-serious side effects often involve Gastrointestinal disorders such as nausea, vomiting, or diarrhea, particularly with large doses. Local reactions, including injection site pain and swelling, are associated with the parenteral route.

The most critical safety concerns are related to the vitamin's metabolic breakdown into oxalate, which primarily impacts the Renal and urinary system.

Serious Adverse Reactions officially documented in regulatory texts include:

  • Oxalate Nephropathy and Nephrolithiasis: Risk of kidney damage or stone formation, particularly associated with prolonged administration of high doses.
  • Severe Hemolysis: Destruction of red blood cells, a risk strictly confined to individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Population-Specific Constraints and Limitations

Specific patient populations are subject to explicit safety constraints. Individuals with pre-existing Renal impairment or a history of kidney stone formation have an increased risk of renal complications. The risk of hemolysis requires mandated caution for patients with G6PD deficiency.

Furthermore, Acide Ascorbique is a reducing agent and can interfere with numerous clinical laboratory tests, potentially resulting in false readings for assays such as urine or blood glucose. The rapid intravenous administration of the solution may also lead to transient effects like faintness or dizziness.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes that overdose of ascorbic acid (Acide Ascorbique Renaudin) may lead to specific patterns of systemic toxicity, particularly involving the gastrointestinal and urinary systems. These manifestations typically occur with chronic ingestion or high-dose intravenous administration.

Overdose Symptoms and Risks

System Affected Documented Overdose Manifestations
Gastrointestinal Nausea, vomiting, and diarrhea.
Urinary/Renal Risk of oxalate and uric acid crystal formation (crystalluria) and stone formation. High-dose intravenous use is associated with acute oxalate nephropathy (kidney damage).

When to Seek Immediate Medical Help

Immediate emergency medical attention must be sought by calling emergency services (e.g., 911) or a Poison Control Center if an overdose is suspected or if severe symptoms occur.

Regulatory documentation highlights that certain individuals face a heightened risk of serious adverse effects from high doses. Patients with pre-existing renal disease (kidney impairment), those with a history of oxalate kidney stones, and individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at increased risk of serious toxicity, such as acute oxalate nephropathy or hemolysis, respectively. Treatment for an overdose is generally symptomatic and supportive.

Therapeutic Uses of Acide Ascorbique Renaudin

Acide Ascorbique Renaudin is commonly used to help manage health issues associated with nutritional deficits and temporary physiological stress. It is relevant in therapeutic contexts where additional symptomatic support is needed for nutritional deficits and various symptom clusters.


What Acide Ascorbique Renaudin Treats: Main Uses and Benefits

This medication is primarily relevant for the treatment and prevention of vitamin C deficiency (scurvy) and is applied when appropriate as a supportive treatment for periods of transient asthenia (temporary fatigue). It also plays a role in managing processes related to tissue health and may assist with non-heme iron absorption. These applications are relevant across conditions involving episodic or fluctuating manifestations or those marked by increased physiological stress.

The primary patient-oriented benefit is the support it provides in easing the overall symptom burden. It is applied in addressing symptoms that interfere with daily comfort, such as pronounced manifestations of deficiency (e.g., bleeding gums and poor wound healing), and supports patients during phases of increased distress associated with fatigue. This approach contributes to supporting a sense of functional stability when symptoms are more noticeable.


Quick Fact: Relief for Deficiency Symptoms The medicine is used to manage symptom clusters that may become intense or disruptive due to a severe lack of vitamin C.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Acide Ascorbique Renaudin

Official regulatory labeling strictly defines the populations eligible for use of this injectable medicine, based on age, specific medical conditions, and physiological status.


Absolute Contraindications

Use is strictly contraindicated for individuals with known hypersensitivity to Ascorbic Acid, and those with underlying conditions that increase the risk of oxalate accumulation, such as severe renal impairment (creatinine clearance < 30 mL/min), hyperoxaluria, or a history of oxalocalcic urinary stones. The medicine is also prohibited in patients with iron overload disorders (e.g., hemochromatosis).


Conditional Use and Restrictions

Population Group Regulatory Status
Age 5 Months and Older Eligible (Standard Use)
Infants under 5 Months Not Recommended (Use not established)
Renal Impairment Conditional Use (Requires monitoring)
G6PD Deficiency Conditional Use (Requires reduced dose and monitoring)
Pregnancy/Lactation Conditional Use (High doses not recommended)
Geriatric Patients Caution (Increased risk for renal complications)

Use is generally limited to short-term parenteral administration. Eligibility is restricted in young children (under two years old) and older adults, who require monitoring due to the risk of oxalate nephropathy.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Acide Ascorbique Renaudin


Interaction Scope

Category Official Regulatory Information
Medicinal product categories with documented interactions Basic Drugs and Acidic Drugs, Oral Anticoagulants (e.g., Warfarin), Phenothiazines, Aluminum-containing Antacids, and specific classes of Antibiotics.
Specific interacting medicines (if explicitly listed) Deferoxamine (Desferrioxamine), Amphetamine, Fluphenazine, Ethinyloestradiol, and Bleomycin.
Mechanistic basis of interactions (only if stated in label) Alters renal tubular reabsorption (via urine pH changes), potentiation of toxicity (iron chelation-related), enhancement of gastrointestinal absorption, inactivation (in vitro chemical incompatibility).
Timing-based interaction rules (if applicable) Co-administration with Deferoxamine must be avoided for the first month after starting the chelator treatment. Interference with certain laboratory tests requires a delay of 24 hours after infusion.
Population-specific interaction notes (if applicable) The interaction with Deferoxamine is restricted in patients with cardiac dysfunction. The interaction with Aluminum-containing Antacids poses a heightened risk for patients with kidney failure.
Interaction-related restrictions Do not combine with Deferoxamine in patients with cardiac dysfunction. Administration timing is restricted for Deferoxamine in all other patients.

Interaction Classifications (High-Level)

Classification Official Regulatory Description
Interaction severity classification (as defined in official documents) Contraindicated in a specific patient group (Deferoxamine in cardiac dysfunction); Risk of altered efficacy or exposure (Warfarin, Phenothiazines, Basic/Acidic Drugs); Risk of toxicity (Aluminum Antacids).
Regulatory basis (EMA / FDA / etc.) Regulatory data are sourced from government-approved documents including FDA Prescribing Information and European Medicines Agency (EMA)/National Health Authority SmPC documentation.
Interaction-context constraints (as defined in official documents) Interactions exist with non-medicinal substances (Alcohol, Nicotine, Oral Contraceptives) and diagnostic procedures.

Resulting Interaction Structure

Official Interaction Statements:

  • Co-administration with Deferoxamine may worsen iron toxicity, leading to cardiac failure; this combination is contraindicated in patients with cardiac dysfunction.
  • Urine acidification can lead to decreased serum levels for basic drugs like Amphetamine and Fluphenazine, and may reduce the response to Warfarin at high doses.
  • The drug enhances the gastrointestinal absorption of aluminum, increasing the risk of toxicity, specifically for patients with kidney failure taking Aluminum-containing Antacids.
  • Certain oxidation-reduction laboratory tests require a delay of 24 hours after infusion to prevent assay interference with results.
  • Oral Contraceptives, alcohol, and nicotine are officially documented to affect systemic ascorbic acid levels, potentially leading to lower serum levels.

Connection to the overall interaction profile (2–4 sentences):

Regulatory documents define the product's interaction structure primarily through two mechanisms: the modification of renal clearance for other medicines due to the potential for urine acidification, and the potentiation of toxicity from chelation in specific clinical scenarios, such as with Deferoxamine. The profile also contains specific, formal restrictions concerning the timing of administration and explicit identification of interactions with non-medicinal substances like alcohol and nicotine that affect the drug's own systemic exposure.

Mechanism of Action

Modulation of Cellular Redox Homeostasis

Acide Ascorbique Renaudin (ascorbic acid) functions as a reducing agent by readily donating electrons to neutralize reactive oxygen species (ROS) like free radicals within the aqueous cellular compartments. This mechanism directly influences the cell's redox homeostasis, which consequently affects the stability of biological structures and participates in the regulation of processes associated with oxidative stress.


Cofactor Support for Biosynthetic Pathways

The compound acts as an essential enzyme cofactor, particularly for hydroxylase enzymes crucial for the post-translational modification required in collagen biosynthesis and the formation of certain neurotransmitters (catecholamines). This engagement is necessary to ensure the correct structure and function of these structural proteins, contributing to physiological consequences related to tissue integrity.


Influence on Iron Metabolism and Absorption

Ascorbic acid initiates a specific mechanistic cascade by reducing ferric iron (Fe^3+) to the more absorbable ferrous state (Fe^2+) within the gastrointestinal lumen. This targeted effect on mineral bioavailability modulates the systemic supply of iron, influencing mechanisms that regulate the utilization of iron for oxygen transport and the function of various iron-dependent enzymes.

Dosage and Administration Information

How to Use Acide Ascorbique Renaudin

Acide Ascorbique Renaudin is a parenteral formulation intended solely for administration by qualified healthcare professionals according to strict guidelines. The medicine is primarily administered via Intravenous (IV) injection or infusion, but some protocols also permit Intramuscular (IM) or Subcutaneous (SC) routes.


Official Dosing and Administration Protocol

The usage protocol is standardized around a short-term, daily regimen. For treating scurvy (severe deficiency), adult doses typically range from 100 mg to 500 mg daily. Standard regimens include 200 mg once daily for up to one week, after which a lower maintenance dose may be used. For acute, severe cases, doses up to 1 gram per day may be administered, often given in divided doses.

Preparation and Procedural Constraints

Crucially, the solution is not administered undiluted when given intravenously. Prior to IV administration, the concentrated Ascorbic Acid must undergo mandatory dilution with compatible infusion fluids (e.g., Sodium Chloride or Dextrose Injection). The infusion must be performed as a slow injection or slow infusion to ensure proper distribution.

Age-Specific Use

Specific dosing instructions exist for children. Pediatric patients (e.g., children 5 months to 11 years) are given a lower dose, typically in the range of 50 mg to 100 mg once daily for scurvy. The fixed course of use is designed to be short-term, generally continuing only until the clinical signs of deficiency have resolved, which may require at least two weeks, though some protocols restrict acute use to one week.


This defined procedural structure, covering the route, mandatory preparation, fixed dose range, and duration, governs the standardized use of the injectable medicine.

Recent Clinical Evidence

Acide Ascorbique Renaudin: Research Evidence Overview

The clinical evidence for injectable Acide Ascorbique Renaudin centers primarily on its essential role in correcting severe Vitamin C deficiency (scurvy). Research includes historical case reports and clinical experience, supplemented by short-term pharmacokinetic (PK) studies that examine the restoration of plasma and leukocyte ascorbic acid concentrations in diagnosed adults and pediatric patients. Findings describe patterns related to the return to corrected Vitamin C status, but the evidence base relies heavily on historical data, as modern large-scale trials for scurvy are uncommon.

Research has also explored the use of injectable ascorbic acid during periods of physiological strain, such as in supportive care contexts. Studies, including small-scale randomized controlled trials (RCTs) and observational cohorts, have examined outcomes in critically ill patients, monitoring biomarkers and clinical variables. The findings were mixed when evaluating hard endpoints like length of hospital stay. Evidence is limited due to the heterogeneity of patient groups and the use of very high doses, which limits the certainty of applying those findings broadly.

Injectable ascorbic acid was studied for its supportive role in tissue integrity and wound healing, given its essentiality for collagen formation. While pilot studies report patterns related to wound closure, the evidence quality varies and often involves small sample sizes or supportive care regimens, making it challenging to isolate the specific contribution of the injection.

Long-term effects are not fully established regarding the durability of Vitamin C status correction. Furthermore, data for certain groups remain insufficient, with limited information available beyond adults and children specifically diagnosed with deficiency. Research so far contributes to the broader evidence landscape, but significant gaps remain regarding high-dose utility and long-term functional outcomes.

Key Studies & References

  1. Vitamin C Deficiency - Nutritional Disorders - Merck Manual Professional Edition (Reference for Scurvy treatment)
  2. Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens
  3. Vitamin C promotes wound healing through novel pleiotropic mechanisms (Review of translational evidence)

Frequently Asked Questions (FAQ)

Common questions about Acide Ascorbique Renaudin (FAQ)

Q: What is the main difference between Acide Ascorbique Renaudin and regular Vitamin C supplements?

Official information indicates that Acide Ascorbique Renaudin is a sterile parenteral formulation, meaning it is administered by injection. The injectable route is used primarily for patients with acute deficiency or when the body may not properly absorb Vitamin C taken by mouth. This drug is indicated for specific clinical needs defined by regulatory sources.

Q: Why is this drug given as an injection instead of a pill?

The injectable administration is primarily used for patients who have an acute deficiency of Vitamin C or when the absorption of oral Vitamin C is uncertain due to certain health conditions. The parenteral route is associated with rapid systemic delivery and is indicated when oral absorption may be unreliable.

Q: Is Acide Ascorbique Renaudin the same as 'high-dose vitamin C' mentioned in health discussions?

Regulatory documents list the standard doses used for correcting deficiency. However, they also refer to the administration of higher doses in clinical contexts. Official product information notes that administration of higher doses is associated with an increased potential for certain adverse reactions, including renal complications.

Q: Does Acide Ascorbique Renaudin make you feel tired after the administration?

Adverse reaction lists derived from regulatory sources include potential side effects like unusual drowsiness, dullness, or fatigue. These effects are noted as possibilities in the product's safety information, but the frequency of occurrence is often not stated.

Q: Can children receive Acide Ascorbique Renaudin?

Official documentation states that the use of ascorbic acid injection has been studied in children 5 months of age and older. Use in children younger than 5 months is generally not within the scope of established use defined in official documents.

Q: Are there any specific foods or drinks that should be avoided when receiving this medication?

Official interaction statements specifically list alcohol and nicotine as substances that can potentially reduce the level of ascorbic acid in the system. Beyond these, regulatory documents do not list specific restrictions regarding common food or beverage consumption.

Q: Is it true that Acide Ascorbique Renaudin is sometimes used for patients with burns?

Official documents state that the medicine is indicated for use in the treatment of burns. Official guidance suggests that the daily doses used for severe burns are determined by the extent of the tissue injury.

Q: What should I do if the area of the injection site becomes red or painful?

Regulatory-sourced safety profiles indicate that pain, swelling at the injection site, and transient soreness are possible local effects of the medication. These effects are typically managed by the healthcare professional administering the drug.

Q: Is it common to feel nauseous after taking Acide Ascorbique Renaudin?

Regulatory-based side effect profiles frequently list nausea and vomiting as potential adverse reactions. This is particularly noted when larger doses of the medicine are administered to the patient.

Q: Can Acide Ascorbique Renaudin affect blood sugar levels?

Official safety information notes that the drug may act as an interfering substance in certain laboratory assays. For example, diabetics taking more than a certain amount of the medicine may obtain false readings when conducting urinary glucose tests.

Q: What is the reason a doctor might prescribe Acide Ascorbique Renaudin?

The medicine is primarily prescribed for the prevention and treatment of scurvy, which is severe Vitamin C deficiency. It is also indicated in cases of acute deficiency or when the doctor determines that the patient cannot reliably absorb the vitamin through the oral route.

Q: Is there a maximum number of times a person can receive this treatment?

Official dosing guidelines describe a short-term regimen designed to correct the deficiency. Regulatory documents emphasize that the risk of serious side effects, such as kidney stone formation, is associated with the prolonged administration of high doses.

Q: Does the body store Acide Ascorbique Renaudin, or is it quickly eliminated?

Ascorbic acid is a water-soluble vitamin, which means it is generally not stored in the body in significant amounts. If more is administered than the body can use, official sources indicate that the excess Vitamin C is passed into the urine.

Q: Are there any known long-term side effects from using this medication?

The main long-term risk noted in official regulatory documents is the potential for oxalate nephropathy (kidney damage) and renal stone formation. This serious concern is specifically associated with the prolonged administration of high doses of the medicine.

Q: How does a doctor decide if a patient is eligible for this treatment?

Clinical decision-making is based on the presence of a confirmed deficiency or malabsorption issue. The decision also involves the evaluation against strict regulatory contraindications, such as severe renal impairment or G6PD deficiency.

Q: Does this medication require a prescription?

Yes. Regulatory bodies classify the injectable form of ascorbic acid as a Human Prescription Drug. Its administration requires a prescription and must be performed by a trained health professional in a clinical setting.

Q: What are the signs of a severe but rare side effect of Acide Ascorbique Renaudin?

Severe, rare effects include hemolysis (red blood cell breakdown) in patients with G6PD deficiency, with signs like fever, dark urine, or yellow eyes/skin. Renal complications may be indicated by lower back pain or a decrease in the amount of urine.

Q: Does the research suggest Acide Ascorbique Renaudin supports the immune system?

Official and authoritative medical sources note the drug's role in the body as an antioxidant, a function that is integral to cellular protection. This mechanism is cited as part of the overall essential role Vitamin C plays in supporting the immune system.

Q: What is the purpose of the liquid carrier solution in the injection?

Regulatory documents specify that the active ingredient is formulated with components like Sodium Bicarbonate and Water for Injection. This creates a buffered solution that maintains a stable, neutral pH, which is necessary to maintain the solution's stability and physiological compatibility for use.

Q: What should be done if the injection leaks out of the vein?

Official warnings note that care should be taken during administration to avoid extravasation (leakage outside the vein), as this can lead to local adverse reactions such as inflammation along the vein (thrombophlebitis).

Q: What makes Acide Ascorbique Renaudin different from vitamin C found in fruits and vegetables?

The medicine is a sterile, highly concentrated solution administered via injection, ensuring a precise and high systemic dose. This delivery method bypasses the natural absorption limits and variability associated with taking Vitamin C through food sources.

Q: Are there specific laboratory tests required before receiving Acide Ascorbique Renaudin?

Official guidance indicates that specific medical conditions should be assessed due to safety constraints. Patients are typically screened for Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Renal function (kidney health) should also be assessed because of the risk of kidney complications.

Q: Can people with high blood pressure use this medication?

While high blood pressure is not typically listed as a direct side effect, regulatory-sourced information notes that a decrease in the frequency or amount of urine or an increase in blood pressure can be signs of serious kidney complications. The potential for changes in blood pressure or kidney function means that patients with existing conditions are typically monitored closely during treatment.

Q: Is there a risk of interference with urine test results while on this medication?

Yes, official safety information states that the drug may interfere with laboratory tests based on oxidation-reduction reactions. For instance, high doses of the medication may cause false readings of urinary glucose tests in patients with diabetes.

Q: Does this product contain any allergens like gluten or soy?

Official documents list the specific inactive ingredients, such as Sodium Bicarbonate and Water for Injection. While common allergens are not typically listed, the product is officially contraindicated in individuals with a known hypersensitivity to the active ingredient or any component of the formulation.

Q: Does Acide Ascorbique Renaudin interact with common over-the-counter pain relievers?

Official interaction documents classify the drug as having potential interactions with Acidic and Basic Drugs, which includes many over-the-counter medicines. These interactions primarily involve potential changes in how the other medicines are cleared by the kidneys, which may alter their effects.

Q: What kind of studies support the use of Acide Ascorbique Renaudin?

Studies supporting the drug's use include historical case reports and short-term pharmacokinetic studies related to correcting Vitamin C status. Research has also examined the drug's use in supportive care contexts, such as for critically ill patients and in conditions related to tissue injury like burns.

Q: What official guidance say about its use during pregnancy?

Official guidance classifies the drug as having conditional use during pregnancy and lactation. Regulatory documents specifically caution that high doses are not recommended during this time.

Q: Is Acide Ascorbique Renaudin generally considered safe for elderly patients?

Official eligibility profiles list caution for geriatric patients due to the potential for increased risk of renal complications. These factors are considered during treatment evaluation.

Q: What are the potential interactions with herbal supplements?

Official interaction maps detail interactions with other medicines, alcohol, and nicotine. However, the regulatory documentation summary does not explicitly include or list specific interactions with herbal supplements.

Q: Is it possible to be allergic to Acide Ascorbique Renaudin?

Official product information strictly lists hypersensitivity to the active ingredient as an absolute contraindication. As with any drug, the potential for an allergic reaction is a factor that must be considered before use.

Q: What is the general expectation for improvement after the treatment course?

Research focuses on the restoration of Vitamin C status in the plasma and cells. While findings regarding certain clinical outcomes are described as mixed, the expectation is the correction of the deficiency symptoms, which is achieved after a short-term treatment regimen.

Q: What is the clinical evidence regarding Acide Ascorbique Renaudin and iron absorption?

The drug's mechanism of action is formally described as one that facilitates iron absorption by changing the state of the iron. While this mechanism is known, the official research overview primarily focuses on correcting Vitamin C deficiency and studies of the drug in supportive care contexts.

Q: Does the evidence point to any effect of Acide Ascorbique Renaudin on wound healing?

Ascorbic acid is essential for collagen formation, a process critical for tissue integrity and wound healing. While pilot studies report patterns related to wound closure, regulatory summaries note that the evidence quality varies and may involve small sample sizes.

How should Acide Ascorbique Renaudin be stored and disposed of?

Storage and Disposal Profile

The storage and disposal requirements for Acide Ascorbique Renaudin (Ascorbic Acid Injection) are mandated by regulatory agencies to maintain the product's chemical stability and sterility.

Storage Category Official Requirements
Temperature Store at Controlled Room Temperature (typically 20 C to 25 C) or as required by the specific label; Do not freeze.
Protection Protect from light; keep in the original outer carton until use.
Stability/Handling This is a single-use preparation. Contents must be used immediately after opening or dilution, and any unused portion must be discarded.
Child Safety Keep the medicine out of the sight and reach of children.
Disposal Dispose of all unused product and waste material in accordance with local regulations; do not discard in household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acide Ascorbique Renaudin found in:

A-Z Index: